 |
 |
 |
Goldline Pharmaceutical IPO Details, Price, Market Lot
Goldline Pharmaceutical IPO Details |
|
| IPO Open Date | |
| IPO Close Date | |
| IPO Issue Size | |
| Issue (Sale Type) | |
| Fresh Issue | |
| Offer for Sale | |
| Offered to Public | |
| Reserved for Market Maker | |
| Market Maker | |
| Share Holding (Pre Issue) | |
| Share Holding (Post Issue) | |
| Listing At | |
Goldline Pharmaceutical IPO Price |
|
| has set a price band of , lot size is of and face value is . | |
| Face Value | |
| Price Band | ₹41 to ₹43 per share |
| Lot Size | 3,000 shares |
| IPO Issue Type | |
Goldline Pharmaceutical IPO Time Table |
|
| IPO will open for subscription on and close on . Basis of Allotment will be decided on , initiation of refund will begin on and IPO will be listed on at . | |
| IPO Open Date | |
| IPO Close Date | |
| Basis of Allotment Date | |
| Initiation of Refunds | |
| Credit of Share to Demat Account | |
| IPO Listing Date | |
| IPO Cut-off time (UPI mandate confirmation) | |
Goldline Pharmaceutical IPO Reservation |
|
| Total shares offered by IPO is . Out of which is reserved for retail, is reserved for HNI (NII), is reserved for QIB, and is reserved for market maker . | |
| Retail Quota | |
| NII Quota | |
| QIB Quota | |
| Market Maker Quota | |
| Total | |
Company Promotor & Promotor's Holding |
|
| Pre Issue Promotor Holding | |
| Post Issue Promotor Holding | |
Goldline Pharmaceutical IPO Registrar |
|
Goldline Pharmaceutical IPO Lead Manager |
|
| is the book running lead manager, is the registrar and the market maker of the IPO | |
IPO Financial Indicator (valuations) |
|
| Market Capitalization | |
| Debt/Equity | |
| ROE | |
| ROCE | |
| RONW | |
| P/BV | |
| PAT Margin | |
| EBITDA | |
Goldline Pharmaceutical IPO P/E ratio and EPS |
|
| EPS (Pre IPO) | |
| EPS (Post IPO) | |
| P/E ratio (Pre IPO) | |
| P/E ratio (Post IPO) | |
Goldline Pharmaceutical IPO Lot Size and Required Amount
has set a price band of and lot size is of . Retail investors can bid for a minimum and maximum of lots ( shares), requiring an investment of . Small HNI (sHNI) investors can bid for a minimum of lots ( shares), requiring an investment of and maximum of lots ( shares), requiring an investment of . Big HNI (bids > 10 Lakh, bHNI) investors can bid for a minimum of Lots ( shares), requiring an investment of . Calculated at the cut-off price (the upper end of the price band).
| Number of Shares Per Lot = | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Minimum) | |||
| Retail (Maximum) | |||
| S-HNI (Minimum) | |||
| S-HNI (Maximum) | |||
| B-HNI (Minimum) | |||
| Number of Shares Per Lot = | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Min) | |||
| Retail (Max) | |||
| S-HNI (Min) | |||
| S-HNI (Max) | |||
| B-HNI (Min) | |||
| Contact & Address | |
| Address: Phone: Email: Website: |
|
| IPO Prospectus | |
Goldline Pharmaceutical IPO FAQs
Goldline Pharmaceutical IPO is an SME IPO. The company will raise upto 11 crore 61 lakh rupees for 27,00,000 shares. Face value is ₹10 per share, Price band is ₹41 to ₹43 per share, and cutt off price is ₹43 per share. The IPO opens on 12 May 2026 and closes on 14 May 2026. Bigshare Services Pvt Ltd is the registrar and shares of Goldline Pharmaceutical IPO will be listed at BSE SME.
The issue size of IPO is 27,00,000 shares (aggregating up to 11 crore 61 lakh rupees). For fresh issue: 27,00,000 shares (aggregating up to 11 crore 61 lakh rupees) and for offer for sale: NIL.
Price band for IPO is ₹41 to ₹43 per share.
The lot size of Goldline Pharmaceutical IPO is of 3000. Minimum order quantity for retail investor is 6,000 shares (2 lots) and required amount is ₹2,58,000. Minimum order quantity for sHNI is 9,000 shares ( lots) and required amount is ₹3,87,000. Minimum order quantity for bHNI investor is 24,000 shares ( lots) and required amount is ₹10,32,000.
The investors portion reserved for QIB is 12,72,000 shares (47.11%), reserved for HNI is 3,90,000 shares (14.44%) and 9,00,000 shares (33.33%) reserved for retail investors.
The IPO will be available for subscription from 12 May 2026 to 14 May 2026. IPO open date is 12 May 2026 and close date is 14 May 2026.
Allotment date for IPO is 15 May 2026. On the allotment date, after the IPO allotment status is announced, investors can check their IPO application allotment status on their respective IPO registrar.
The registrar for IPO is Bigshare Services Pvt Ltd.
The IPO will be listed on 19 May 2026 at BSE SME.